{"name": "Kolltan Pharmaceuticals",
 "permalink": "kolltan-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/kolltan-pharmaceuticals",
 "homepage_url": "http://www.kolltan.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "nfo@kolltan.com",
 "phone_number": "203-773-3000",
 "description": "Antibody Oncology Therapeutics",
 "created_at": "Tue Oct 13 01:58:10 UTC 2009",
 "updated_at": "Tue Apr 24 02:32:05 UTC 2012",
 "overview": "\u003Cp\u003EKolltan Pharmaceuticals, Inc. develops new generation monoclonal antibody oncology therapeutics. Its products are developed based in receptor tyrosine kinase. The company was founded in 2007 and is based in New Haven, Connecticut.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       44],
      "assets/images/resized/0006/2551/62551v1-max-150x150.jpg"],
     [[186,
       55],
      "assets/images/resized/0006/2551/62551v1-max-250x250.jpg"],
     [[186,
       55],
      "assets/images/resized/0006/2551/62551v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Gerald",
      "last_name": "McMahon",
      "permalink": "gerald-mcmahon",
      "image": null}},
   {"is_past": false,
    "title": "Co-Founder, Chairman of the Board",
    "person":
     {"first_name": "Arthur",
      "last_name": "Altschul Jr.",
      "permalink": "arthur-altschul-jr",
      "image":
       {"available_sizes":
         [[[80,
            80],
           "assets/images/resized/0007/2021/72021v1-max-150x150.jpg"],
          [[80,
            80],
           "assets/images/resized/0007/2021/72021v1-max-250x250.jpg"],
          [[80,
            80],
           "assets/images/resized/0007/2021/72021v1-max-450x450.jpg"]],
        "attribution": "\u003Cp\u003EKolltan\u003C/p\u003E"}}},
   {"is_past": false,
    "title": "Co-Founder",
    "person":
     {"first_name": "Michael",
      "last_name": "Schmertzler",
      "permalink": "michael-schmertzler",
      "image": null}},
   {"is_past": false,
    "title": "Co-Founder",
    "person":
     {"first_name": "Joseph",
      "last_name": "Schlessinger",
      "permalink": "joseph-schlessinger",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Thomas",
      "last_name": "Neff",
      "permalink": "thomas-neff",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Axel",
      "last_name": "Bolt",
      "permalink": "axel-bolt",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$40M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/kolltan-pharmaceuticals-inc-series-a-5m/",
    "source_description": "Kolltan Pharmaceuticals, Inc.: Series A $5M",
    "raised_amount": 5000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 10,
    "funded_day": 12,
    "investments":
     [{"company":
        {"name": "Purdue Pharma",
         "permalink": "purdue-pharma",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0006/2658/62658v1-max-150x150.png"],
             [[150,
               78],
              "assets/images/resized/0006/2658/62658v1-max-250x250.png"],
             [[150,
               78],
              "assets/images/resized/0006/2658/62658v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.finsmes.com/2010/01/kolltan-pharmaceuticals-closes-10m.html",
    "source_description": "Kolltan Pharmaceuticals Closes $10M Series B Financing",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 20,
    "investments":
     []},
   {"round_code": "c",
    "source_url": "http://www.masshightech.com/stories/2012/03/05/daily40-Kolltan-Pharma-raises-25M-in-equity-offering.html",
    "source_description": "Kolltan Pharma raises $25M in equity offering",
    "raised_amount": 25000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 3,
    "funded_day": 8,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "300 George Street",
    "address2": "Suite 530",
    "zip_code": "06511",
    "city": "New Haven",
    "state_code": "CT",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/2349/72349v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/2349/72349v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/2349/72349v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}